1244 related articles for article (PubMed ID: 26088696)
1. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
2. Tissue transglutaminase colocalizes with extracellular matrix proteins in cerebral amyloid angiopathy.
de Jager M; van der Wildt B; Schul E; Bol JG; van Duinen SG; Drukarch B; Wilhelmus MM
Neurobiol Aging; 2013 Apr; 34(4):1159-69. PubMed ID: 23122413
[TBL] [Abstract][Full Text] [Related]
3. The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy.
de Jager M; Boot MV; Bol JG; Brevé JJ; Jongenelen CA; Drukarch B; Wilhelmus MM
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):255-72. PubMed ID: 25871449
[TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase: a novel therapeutic target in cerebral amyloid angiopathy.
Wilhelmus MM; de Jager M; Drukarch B
Neurodegener Dis; 2012; 10(1-4):317-9. PubMed ID: 22156619
[TBL] [Abstract][Full Text] [Related]
5. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
6. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death.
Bruinsma IB; Wilhelmus MM; Kox M; Veerhuis R; de Waal RM; Verbeek MM
Brain Res; 2010 Feb; 1315():169-80. PubMed ID: 20034483
[TBL] [Abstract][Full Text] [Related]
8. Aβ immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy.
Sakai K; Boche D; Carare R; Johnston D; Holmes C; Love S; Nicoll JA
Acta Neuropathol; 2014 Dec; 128(6):777-89. PubMed ID: 25195061
[TBL] [Abstract][Full Text] [Related]
9. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
10. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.
Tanskanen M; Lindsberg PJ; Tienari PJ; Polvikoski T; Sulkava R; Verkkoniemi A; Rastas S; Paetau A; Kiuru-Enari S
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):589-99. PubMed ID: 16281907
[TBL] [Abstract][Full Text] [Related]
11. Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen.
Tian J; Shi J; Smallman R; Iwatsubo T; Mann DM
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):332-40. PubMed ID: 16640651
[TBL] [Abstract][Full Text] [Related]
12. Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target.
Wilhelmus MM; de Jager M; Bakker EN; Drukarch B
J Alzheimers Dis; 2014; 42 Suppl 3():S289-303. PubMed ID: 24685636
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular A beta clearance.
Prior R; Wihl G; Urmoneit B
Ann N Y Acad Sci; 2000 Apr; 903():180-6. PubMed ID: 10818506
[TBL] [Abstract][Full Text] [Related]
14. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR
J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
Cho HS; Hyman BT; Greenberg SM; Rebeck GW
J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
[TBL] [Abstract][Full Text] [Related]
16. Interaction between tissue transglutaminase and amyloid-beta: Protein-protein binding versus enzymatic crosslinking.
Wilhelmus MMM; Jongenelen CA; Bol JGJM; Drukarch B
Anal Biochem; 2020 Mar; 592():113578. PubMed ID: 31923381
[TBL] [Abstract][Full Text] [Related]
17. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
[TBL] [Abstract][Full Text] [Related]
18. Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease.
Allen N; Robinson AC; Snowden J; Davidson YS; Mann DM
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):136-48. PubMed ID: 23808763
[TBL] [Abstract][Full Text] [Related]
19. Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models.
Wilhelmus MM; de Jager M; Smit AB; van der Loo RJ; Drukarch B
Sci Rep; 2016 Feb; 6():20569. PubMed ID: 26837469
[TBL] [Abstract][Full Text] [Related]
20. LRP1 expression in cerebral cortex, choroid plexus and meningeal blood vessels: relationship to cerebral amyloid angiopathy and APOE status.
Ruzali WA; Kehoe PG; Love S
Neurosci Lett; 2012 Sep; 525(2):123-8. PubMed ID: 22967844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
